The role of Imaging and Radiation Oncology Core for precision medicine era of clinical trial.

Related Articles

The role of Imaging and Radiation Oncology Core for precision medicine era of clinical trial.

Transl Lung Cancer Res. 2017 Dec;6(6):621-624

Authors: Xiao Y, Rosen M

Abstract
Imaging and Radiation Oncology Core (IROC) services have been established for the quality assurance (QA) of imaging and radiotherapy (RT) for NCI's Clinical Trial Network (NCTN) for any trials that contain imaging or RT. The randomized clinical trial is the gold standard for evidence-based medicine. QA ensures data quality, preventing noise from inferior treatments obscuring clinical trial outcome. QA is also found to be cost-effective. IROC has made great progress in multi-institution standardization and is expected to lead QA standardization, QA science in imaging and RT and to advance quality data analysis with big data in the future. The QA in the era of precision medicine is of paramount importance, when individualized decision making may depend on the quality and accuracy of RT and imaging.

PMID: 29218265 [PubMed]

http://ift.tt/2BnOIAP